Literature DB >> 10713678

Regulation of mda-7 gene expression during human melanoma differentiation.

M T Madireddi1, P Dent, P B Fisher.   

Abstract

Induction of irreversible growth arrest and terminal differentiation in human melanoma cells following treatment with recombinant human fibroblast interferon (IFN-beta) and mezerein (MEZ) results in elevated expression of a specific melanoma differentiation associated gene, mda-7. Experiments were conducted to define the mechanism involved in the regulation of mda-7 expression in differentiating human melanoma cells. The mda-7 gene is actively transcribed in uninduced HO-1 human melanoma cells and the rate of transcription of mda-7 is not significantly enhanced by treatment with IFN-beta, MEZ or IFN-beta+MEZ. The high basal activity of the mda-7 promoter in uninduced melanoma cells and the absence of enhancing effect upon treatment with differentiation inducers is corroborated by transfection studies using the promoter region of mda-7 linked to a luciferase reporter gene containing the SV40 polyadenylation signal sequence. RT - PCR analysis detects the presence of low levels of mda-7 transcripts in uninduced and concomitant increases in differentiation inducer treated HO-1 cells. However, steady-state mda-7 mRNA is detected only in IFN-beta+MEZ and to a lesser degree in MEZ treated cells. We show that induction of terminal differentiation of HO-1 cells with IFN-beta+MEZ dramatically increases the half-life of mda-7 mRNA while treatment with cycloheximide results in detectable mda-7 mRNA in control and inducer treated cells. These observations confirm constitutive activity of the mda-7 promoter in HO-1 cells irrespective of differentiation status suggesting posttranscriptional processes as important determinants of mda-7 expression during terminal differentiation. The 3' UTR region of mda-7 contains AU-rich elements (ARE) that contribute to rapid mda-7 mRNA turnover during proliferation and reversible differentiation, a process controlled by a labile protein factor(s). Substitution of the SV40 polyadenylation signal sequence in the luciferase reporter plasmid with the mda-7-ARE-3'-UTR renders the Luciferase message unstable when expressed in proliferating and reversibly differentiated melanoma cells. In contrast, the luciferase message is stabilized when the mda-7-ARE-3'-UTR construct is expressed in terminally differentiated HO-1 cells. These results provide compelling evidence that mda-7 expression during terminal differentiation in human melanoma cells is regulated predominantly at a posttranscriptional level.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713678     DOI: 10.1038/sj.onc.1203424

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins.

Authors:  T Bakheet; M Frevel; B R Williams; W Greer; K S Khabar
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

2.  HDAC4 inhibits the transcriptional activation of mda-7/IL-24 induced by Sp1.

Authors:  Lina Pan; Hong Pan; Hao Jiang; Juan Du; Xiuli Wang; Baiqu Huang; Jun Lu
Journal:  Cell Mol Immunol       Date:  2010-04-12       Impact factor: 11.530

3.  Characterization of the canine mda-7 gene, transcripts and expression patterns.

Authors:  Maninder Sandey; R Curtis Bird; Swadesh K Das; Devanand Sarkar; David T Curiel; Paul B Fisher; Bruce F Smith
Journal:  Gene       Date:  2014-05-24       Impact factor: 3.688

4.  Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis.

Authors:  Moira Sauane; Zao-Zhong Su; Pankaj Gupta; Irina V Lebedeva; Paul Dent; Devanand Sarkar; Paul B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-03       Impact factor: 11.205

Review 5.  MDA-7/IL-24: multifunctional cancer killing cytokine.

Authors:  Mitchell E Menezes; Shilpa Bhatia; Praveen Bhoopathi; Swadesh K Das; Luni Emdad; Santanu Dasgupta; Paul Dent; Xiang-Yang Wang; Devanand Sarkar; Paul B Fisher
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

6.  Molecular Mechanisms Governing IL-24 Gene Expression.

Authors:  Anupama Sahoo; Sin-Hyeog Im
Journal:  Immune Netw       Date:  2012-02-29       Impact factor: 6.303

7.  Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimetic.

Authors:  Siddik Sarkar; Bridget A Quinn; Xue-Ning Shen; Rupesh Dash; Swadesh K Das; Luni Emdad; Alexander L Klibanov; Xiang-Yang Wang; Maurizio Pellecchia; Devanand Sarkar; Paul B Fisher
Journal:  Oncotarget       Date:  2015-05-10

8.  The p38 MAPK regulates IL-24 expression by stabilization of the 3' UTR of IL-24 mRNA.

Authors:  Kristian Otkjaer; Helmut Holtmann; Tue Wenzel Kragstrup; Søren Riis Paludan; Claus Johansen; Matthias Gaestel; Knud Kragballe; Lars Iversen
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

Review 9.  mda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicity.

Authors:  Rupesh Dash; Sujit K Bhutia; Belal Azab; Zhao-zhong Su; Bridget A Quinn; Timothy P Kegelmen; Swadesh K Das; Keetae Kim; Seok-Geun Lee; Margaret A Park; Adly Yacoub; Mohammed Rahmani; Luni Emdad; Igor P Dmitriev; Xiang-Yang Wang; Devanand Sarkar; Steven Grant; Paul Dent; David T Curiel; Paul B Fisher
Journal:  Cytokine Growth Factor Rev       Date:  2010-10       Impact factor: 7.638

Review 10.  mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine.

Authors:  Pankaj Gupta; Zao-zhong Su; Irina V Lebedeva; Devanand Sarkar; Moira Sauane; Luni Emdad; Michael A Bachelor; Steven Grant; David T Curiel; Paul Dent; Paul B Fisher
Journal:  Pharmacol Ther       Date:  2006-02-07       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.